Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Interpreting X̄ Charts01:13

Interpreting X̄ Charts

402
Interpreting x̄ charts, a type of control chart used in statistical process control helps monitor the variation in processes over time. The x̄ chart is based on the sample mean and allows for monitoring variations in the process mean over time. These charts are pivotal for quality assurance in manufacturing and other sectors.
An x̄ chart plots the values of individual measurements over time against control limits calculated from historical data. The central line...
402
Interpreting R Charts01:22

Interpreting R Charts

471
R chart, or range chart, is a fundamental tool in statistical process control used to monitor the variability within a process. It complements the X-bar (x̄) chart by focusing on the range of the data, rather than individual values, providing a clear picture of the process dispersion over time.
An R chart plots the range of subsets of measurements collected from a process. Each point on the chart represents the range—defined as the difference between the maximum and minimum...
471

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world decision-making for post-exposure management of drug-resistant TB.

IJTLD open·2026
Same author

Reply to Schön et al., "Quality control and considering systematic MIC shifts are key when evaluating the role of <i>mmpR5</i> (<i>Rv0678</i>) frameshifts in bedaquiline resistance".

Antimicrobial agents and chemotherapy·2025
Same author

Clinical best practices for caring for people with expanded resistance to newer TB drugs.

IJTLD open·2025
Same author

Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from Armenia.

Antimicrobial agents and chemotherapy·2025
Same author

Geographic information systems analysis to focus TB screening among people born in endemic countries.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Response to Dr Dancer.

The Journal of hospital infection·2024

Related Experiment Video

Updated: Apr 17, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

82.4K

The complexities of Xpert® MTB/RIF interpretation.

C K Lippincott1, M B Miller2, A Van Rie3

  • 1<sup>*</sup>Institute for Global Health & Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA, <sup>†</sup>Right to Care, Johannesburg, South Africa.

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|February 17, 2015
PubMed
Summary

The Xpert MTB/RIF assay accurately detects tuberculosis (TB) and rifampin resistance. However, interpreting results requires careful consideration of clinical context, especially in low-prevalence settings, to avoid misdiagnosis.

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.3K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

15.0K

Related Experiment Videos

Last Updated: Apr 17, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

82.4K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.3K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

15.0K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • The Xpert MTB/RIF assay is a valuable tool for diagnosing tuberculosis (TB) and detecting rifampin (RMP) resistance.
  • Understanding potential interpretation challenges is crucial for optimal assay utilization in various clinical settings.

Observation:

  • Three distinct cases from the United States, a low TB burden country, illustrate complex Xpert testing scenarios.
  • These include rapid RMP resistance detection in a patient with pre-extensively drug-resistant TB, a false-positive RMP resistance result, and detection of Mycobacterium tuberculosis in a culture-negative sample.

Findings:

  • The Xpert assay's performance can be influenced by the pre-test probability of TB or drug-resistant TB.
  • Clinical context is essential for accurate interpretation of Xpert results, particularly in challenging cases.

Implications:

  • These case studies highlight the need for clinicians to integrate Xpert results with patient history and other diagnostic information.
  • Awareness of potential pitfalls can improve the diagnostic accuracy and clinical management of TB and drug-resistant TB.